Segment And Geographic Information

12 Months Ended

Dec. 31, 2015

Segment And Geographic Information [Abstract]

Segment And Geographic Information

19.  Segment and Geographic Information

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, HeRO Graft, ProCol, and PhotoFix.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues.

The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services.  The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.

The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands):

	2015		2014		2013
Revenues:
Medical devices	$	83,081	$	81,883	$	76,194
Preservation services		62,817		62,758		64,498
Othera		--		--		71
Total revenues		145,898		144,641		140,763
Cost of products and preservation services:
Medical devices		18,663		17,167		15,147
Preservation services		36,516		36,183		35,230
Total cost of products and preservation services		55,179		53,350		50,377
Gross margin:
Medical devices		64,418		64,716		61,047
Preservation services		26,301		26,575		29,268
Othera		--		--		71
Total gross margin	$	90,719	$	91,291	$	90,386

Net revenues by product for the years ended December 31, 2015,  2014, and 2013 were as follows (in thousands):

	2015		2014		2013
Products:
BioGlue and BioFoam	$	59,332	$	62,091	$	58,004
PerClot		4,083		4,289		3,494
CardioGenesis cardiac laser therapy		9,419		8,225		8,965
HeRO Graft		7,546		7,131		5,731
ProCol		1,305		147		--
PhotoFix		1,396		--		--
Total products		83,081		81,883		76,194
Preservation services:
Cardiac tissue		28,059		29,437		29,523
Vascular tissue		34,758		33,321		34,975
Total preservation services		62,817		62,758		64,498
Othera		--		--		71
Total revenues	$	145,898	$	144,641	$	140,763

aFor the year ended December 31, 2013 the “Other” designation included grant revenue.

Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2015,  2014, and 2013 were as follows (in thousands):

	2015		2014		2013
U.S.	$	114,978	$	110,533	$	109,325
International		30,920		34,108		31,438
Total revenues	$	145,898	$	144,641	$	140,763

At December 31, 2015 and 2014 over 95% of the long‑lived assets of the Company were held in the U.S., where all of the Company’s manufacturing facilities and the corporate headquarters are located.  At December 31, 2015 and 2014 the Company’s $11.4 million of goodwill was allocated entirely to its Medical Devices segment.